PetMeds widens net loss while sales drop
The company registered a sharp decline in revenue and profitability in 2025, pressured by public buyout attempts.
American online pet pharmaceutical player PetMeds posted a 22% decline in net sales to $40.6 million (€37.4M) in the third quarter (Q3) of fiscal year (FY) 2025, ending 31 Decem…
Did you think it would be this easy? Nope! Just register. It’s free! Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut cursus turpis vel cursus ullamcorper. Sed ante mi, finibus eget porttitor a, tincidunt ac dolor. Vivamus ornare semper lorem, consequat commodo lectus elementum vitae. Cras id mattis urna. Donec rutrum dignissim lacinia. Duis ultricies sapien at ipsum tincidunt.
Sed in iaculis elit, sit amet convallis felis. Pellentesque non justo lectus. Donec sollicitudin lorem in sapien euismod varius at vitae mi. Maecenas ut elit ac risus consectetur vulputate. Praesent vel orci ante. Curabitur egestas dapibus nisi ac laoreet. Nullam a lacinia libero, non fringilla nisl.
You’re out of free articles,
register for unlimited access
Share this story:
